Together with our partner TRICALS, we presented the webinar: Efficient Patient Identification in ALS Clinical Trials; Leveraging the Concept of Fast and Slow Progressors.During this webinar, Prof. Dr. L.H. van den Berg and R.P.A van Eijk talke...
During this webinar Prof. Sven Francque discussed the phase 2 trial results of the Pan-PPAR Agonist Lanifibranor in nonalcoholic steatohepatitis (NASH) patients. Currently there is an unmet need of management of NASH. Lanifibranor is a pan-PPAR (p...
This webinar focussed on the close multilevel links between insulin resistance/T2DM and NAFLD.Topics that are discussed:Epidemiological links between NAFLD, insulin resistance and T2DM Insulin resistance as root cause of NAFLD: mechan...
Together with our partner Brain Research Center, we presented the webinar: Innovative Endpoints in Alzheimer’s Disease Clinical trials.During this webinar, two experts in the field, Dr. Niels Prins and Dr. Jort Vijverberg discussed the ...
Given the high prevalence of NAFLD in the general population, identifying the persons at a high risk for development of cirrhosis is key. During this presentation, Professor Hannes Hagström focussed on methods and strategies to achieve this in di...
During this webinar, hosted by Billy Franks, Prof. Miriam Sturkenboom (UMC Utrecht, the Netherlands) discussed:- The need for a readily available data and analytics network in Europe for generating safety insights and conducting safety assessm...
Joined webinar between our besproke CRO for hearing loss, ENT Clinical and our partner CILcare.During the webinar “Key success criteria for hearing (pre)clinical trials” Prof. Anne Schilder and Dr. Wahid Awad discussed:Preclinical...
Julius Clinical and Amsterdam UMC are proud to present the webinar: Cutting-edge developments in blood-based biomarkers for Alzheimer’s; application in clinical trialsDuring this webinar, Charlotte Teunissen, Professor in Neurochemistry at ...
Curious about the challanges in NASH clinical trials? And how to overcome them? Watch the NASH Clinical webinar: What are the challenges in NASH clinical trials? And how to overcome them?
Personalization is the new king of global outsourcing. Patients are crying out for more flexible, more diverse and less burdensome trial designs, while the ever larger CROs become less versatile with every merger. It’s no surprise that pharma is...
"*" indicates required fields
"*" indicates required fields
